Härter M, Klesse C, Bermejo I, Bschor T, Gensichen J, Harfst T, Hautzinger M, Kolada C, Kopp I, Kühner C, Lelgemann M, Matzat J, Meyerrose B, Mundt C, Niebling W, Ollenschläger G, Richter R, Schauenburg H, Schulz H, Weinbrenner S, Schneider F, Berger M
Institut und Poliklinik für Medizinische Psychologie, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52 (W 26), 20246, Hamburg, Deutschland.
Nervenarzt. 2010 Sep;81(9):1049-68. doi: 10.1007/s00115-010-3084-7.
Unipolar depressive disorders are among the most frequent reasons for utilizing the health care system. Although efficacious treatments are available and further advances have recently been made there is still a need for improving diagnostic and therapeutic procedures. Alignment of treatment on evidence-based treatment guidelines establishes an essential mainstay. The new S3 and National Health Care guidelines on unipolar depression, the compilation of which was coordinated by the German Society of Psychiatry, Psychotherapy and Neurology (DGPPN) and which were approved by 29 scientific and professional associations, is the ambitious effort to present state of the art evidence and clinical consensus for the treatment of depression. For pharmacotherapy of depression differentiated recommendations can be given, also separate from and in addition to psychotherapy.
单相抑郁障碍是使用医疗保健系统的最常见原因之一。尽管有有效的治疗方法,且最近又取得了进一步进展,但仍有必要改进诊断和治疗程序。依据循证治疗指南进行治疗是至关重要的支柱。由德国精神病学、心理治疗与神经病学学会(DGPPN)协调编写并得到29个科学和专业协会认可的关于单相抑郁的新S3和国家医疗保健指南,是为呈现抑郁症治疗的最新证据和临床共识所做出的一项宏伟努力。对于抑郁症的药物治疗,可以给出有区别的建议,这也是独立于心理治疗之外且与之相辅相成的。